Q2 STOCKS TO BUY

Proteostasis Stock at Bottom of Nasdaq After Drug Data, Downgrade

Early data for PTI's cystic fibrosis treatment disappointed analysts

Managing Editor
Jun 7, 2018 at 10:16 AM
facebook X logo linkedin


Proteostasis Therapeutics Inc (NASDAQ:PTI) has fallen to the bottom of the Nasdaq this morning, down 35% to trade at $3.19, after early stage data for the company's cystic fibrosis treatment disappointed analysts -- specifically, its inability to improve lung function. In response, RBC downgraded PTI stock to "sector perform" from "outperform," while more than halving its price target to $5 from $11. 

Looking closer at the charts, PTI stock hit an annual high of $8.61 back in March, before gapping lower in the wake of a scathing short seller report. The security spent the next few months churning in the $4.50--$5.50 range. However, the shares are now on track for their biggest single-session loss since October 2016, and their first close below the 200-day moving average since early March. 

There is ample room for additional downgrades and/or price-target cuts to come down the pike, which could provide more headwinds for the equity. The majority of the brokerages covering the security still rate it a "buy" or "strong buy," and its average 12-month price target of $13.75 is now nearly quadruple PTI's current perch. 

A number of short sellers are likely kicking rocks today. Short interest topped out at a record 3.19 million shares in mid-March, but has since dropped 40% to 1.88 million shares. Nevertheless, this still represents a healthy 13% of PTI's total available float. Short sellers are sitting on the bench today, though, with PTI stock currently on the short-sale restricted list.

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter